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1. Introduction 
It is well established [l] that vitamin Da must be 
hydroxylated on C-25 in the liver and subsequently on 
C-l in the kidney before it can carry out its functions 
in the intestine and bone. The resulting metabolite, 
lo,25dihydroxycholecalciferol (lc~,25-(OH)~-Da)~ 
is the presently known most potent and rapidly active 
analog of vitamin Da and is considered to be the 
hormonal form of the vitamin. Among many synthetic 
analogs, la-hydroxycholecalciferol (lo-OH-Da) has 
the approximately equivalent activity of lc~,25-(OH)~- 
Da, in promoting intestinal calcium transport, bone 
mineral mobilization and curing rickets [2]. 
However, we have recently found [3] that 
la-OH-Da has a very high toxicity. LD,e-Values for 
Abbreviations: la,25-(OH),-D, - la,25dihydroxychole- 
calciferol, la,24-(OH),-D, - la,24-dihydroxycholecalciferol, 
la-OH-D, - lwhydroxycholecalciferol, 24-OH-D, - 24-hyr 
droxycholecalciferol, 24,25-(OH),-D, - 24,25-dihydroxy- 
cholecalciferol, 25-OH-D, - 25-hydroxycholecalciferol, 
l&,24,25-(OH),-D, - l&,24,25-trihydroxycholecalciferol 
Studies on la,24dihydroxycholecalciferol, part I 
la-OH-Da were 476 pg/kg (p.o.), 71 pg/kg (i.v.) in 
male mice and 440 pg/kg (p.o.), 56 fig/kg (i.v.) in 
female mice, respectively. Similar results were 
obtained in rats. In rats, oral administration of 
2.5 pg/kg of la-OH-D3 for 30 days was considered 
to be a nontoxic dose. The cause of death in both 
acute and subacute toxicity experiments might be 
due to hypercalcemia, considering the toxic signs. 
In our continuing search for a less toxic vitamin D 
analog with enhanced and/or specific activity, we 
have now chosen la,24-dihydroxycholecalciferol 
(l&,24-(OH)a-Ds (fig.1) whose chemical synthesis 
has been described previously [4,5]. 
The present report describes the biological activity 
of 10,24-(OH)2-D3 in normal and anephric rats. The 
activities of both stereoisomers of lcr,24-(OH2)-Ds 
are also compared with those of la-OH-Ds. 
2. Materials and methods 
2.1. Intestinal calcium transport and bone mobilization 
Weanling male wistar rats were fed for 4 weeks on a 
vitamin D-deficient low calcium diet (0.003%). At 
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the end of the 4th week, groups of 5 rats (weighing 
about 90 g), which were either intact or bilaterally 
nephrectomized, received intraperitoneally (in 95% 
ethanol) la-OH-D3 or lo,24-(OH)a-Da (0.05 ml/ 
100 g rat). The rats were sacrificed at various time 
from 4-24 h after drug administration, and intestinal 
calcium transport and serum calcium concentration 
were measured. Intestinal calcium-transport assay 
HO* 
was performed as described by Martin and DeLuca [6]. 
’ OH 
Hg 
’ OH Serum calcium concentration was determined by the 
OCPC (o-cresolphthalein comlexone) method [7]. 
10(,24-(Rb(OH)2-D3 1~&24(9-(OH)~-D~ 
2.2. Antirachitic activity 
Fig.1. Structures of lcr,24-dihydroxycholecalciferol isomers. The antirachitic activity of the sterols was examined 
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Fig.2. Effect of vitamin D, analogs on intestinal calcium transport and serum calcium level in vitamin D deficient rats. 2.5 pg/kg of 
the sterols dissolved in 95% EtOH was given intraperitoneally to the rats fed the low calcium, vitamin D-deficient diets for 4 weeks. 
At the indicated times, they were killed for determination of serum calcium concentration and intestinal calcium transport. There 
were 5 rats in each group. The vertical bars represent he SEM. 
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by means of the line-test method [8]. Weanling male 
Wistar rats were maintained in overhanging wire cages 
and fed on a rachitogenic diet (USP) for 3 weeks and 
were given either a single dose or a small daily dose of 
a vitamin Ds analog for 6 days. Seven days after the 
first dose, the rats were killed and their radii (distal- 
end) and ulnae (proximal-end) were removed. 
After cleaning of adhering tissues, each bone was 
cut with a clean sharp blade and a median, longitu- 
dinal section through the juncture of the epiphysis 
and diaphysis was made. The section was rinsed in 
purified water and immediately immersed in 1.5% 
silver nitrate solution for 1 min and rinsed again in 
purified water. The section was exposed, in water, 
to actinic light until the calcified areas develop a 
clearly defined stain. The new calcification epiphy- 
seal plate width) was scored as described in US 
pharmacopeia using vitamin De as a control [8]. 
3. Results 
Both stereoisomers of lo,24(OH)a-Ds and 
lo-OH-Ds stimulate intestinal calcium transport 
and elicit a rise in serum calcium presumebly at the 
expense of bone calcium (bone mineral mobilization) 
(fig.2). lo,24(0H)aDs was active 4 h after adminis- 
tration while lo-OH-D3 was inactive. After 8 h, each 
sterol caused maximum response and the effects 
were almost identical to each other. Itis noted that 
Table 1 
Effect of vitamin D, analogs on intestinal calcium-transport and serum calcium 
in vitamin D-deficient rats 
Compound Dose 
(pg/kg) 
Intestinal calcium- Serum calcium 
transport ?a (S/M) concentration (mg/dl) 
Normal 
(95% Ethanol) 
&OH-D, 
la,24-(OH),-D, 
(24 R Isomer) 
b~,24-(0H)~-D, 
(24 S Isomer) 
Anephric 
(95% Ethanol) 
la-OH-D, 
la,24-(OH),-Da 
(24 R Isomer) 
Ia,24-(OH)s-D, 
(24 S Isomer) 
0.025 i.p. 
0.25 i.p. 
2.5 i.p. 
0.025 i.p. 
0.25 i.p. 
2.5 i.p. 
0.025 i.p. 
0.25 i.p. 
2.5 i.p. 
2.5 i.p. 
2.5 i.p. 
2.5 i.p. 
1.73 * 0.08 (9) 
1.74 t 0.03 (5) 
2.15 ?: 0.21 (5) 
2.72 i: 0.26 (5)’ 
1.92 * 0.08 (5) 
2.83 i 0.39 (5)b 
3.53 i 0.17 (5)C 
1.70 2 0.03 (5) 
2.35 i 0.17 (5)b 
2.58 * 0.19 (5)’ 
1.34 f 0.04 (4) 
1.70 f 0.06 (4)b 
1.76 i 0.10 (4)b 
2.04 f 0.18 (4)b 
4.8 f 0.12 (9) 
4.9 * 0.10 (5) 
5.3 f 0.25 (5) 
5.5 f 0.14 (5)b 
5.3 f 0.20 (5)a 
5.5 f 0.17 (5)b 
5.9 f 0.13 (5)C 
4.6 f 0.08 (5) 
5.0 f 0.17 (5) 
5.5 f 0.19 (5)b 
4.6 f 0.09 (4) 
5.2 f 0.12 (4)b 
5.4 f 0.12 (4)b 
5.2 f 0.08 (4)b 
Student’s t-test 
a Significantly different from control, p < 0.05 
bp < 0.01 
c p < 0.001 
Rats, either intact or bilaterally nephrectomized, were intraperitoneally given the 
sterols and killed 8 h after administration for determination of serum calcium and 
intestinal calcium-transport. There were 4-9 rats in each groups (number in 
parentheses). 
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the S-isomer of lc~,24-(OH)~-Ds lost its effect 24 h 
after administration. This indicates that the S-isomer 
might be rapidly metabolized to an inactive form or 
excreted. la,24-(OH)*-Ds was also as active as 
lo-OH-D3 in anephric rats (table 1). 
4. Discussion 
Fig.3 compares activity of la,24-(OH)*-Ds and 
la-OH-D3 in curing rickets in rats. Both stereoisomers 
of lcu,24-(OH)2-Ds and lo-OH-Ds were active (fig.3). 
lo-OH-Ds was most active, given either as a single 
dose or small daily dose. The R-isomer of l&,24- 
(OH)z-Ds was as active as la-OH-Ds, while the 
S-isomer was less active than vitamin Ds, and it did 
not show any activity when it had been given a 
single dose. This was consistent with the results 
mentioned above that the S-isomer of la,24(OH),-Ds 
had lost its activity 24 h after administration. 
These results revealed that la,24-DHCC was as 
active as lo-OH-Ds on intestine and bone both in 
intact and anephric rats and that the S-isomer had a 
short duration of action. 
Contrary to la-hydroxylation, the physiological 
meaning of 24-hydroxylation of vitamin D has not 
yet been clarified, although several factors are known 
to be involved [ 1].24_Hydroxycholecalciferol 
(24-OH-Ds) [9] and 24,25dihydroxycholecalciferol 
(24,25-(OH),-D,) [lo] are as active as 25-hydroxy- 
cholecalciferol(25OH-Ds) in stimulating intestinal 
calcium transport in vitamin D deficient rats. However, 
their 24 S stereoisomers have little or no activity in 
the mobilization of calcium from bone, in the eleva; 
tion of serum phosphorus or in the calcification of 
bone, while the 24 R isomers are almost as active as 
25OH-D3 in all of these systems [9,10]. Since these 
sterols were inactive both on intestine and bone in 
anephric rats [9,10] they presumably function after 
being hydroxylated on C-l. It has been also demon- 
strated that la,24,25-trihydroxycholecalciferol 
(lo,24,25(OH)s-Ds) has a preferential action on 
iYiULTIPLE DOSE A SINGLE DOSE 
SCORE SCORE 
012 34 
VITAMIN D, 
** 
I- 
** 
1~,24(R)-(OH),-D, 
la,24W-(OH),-D, * N=7 
c 
** 
M-OH-D, 
N=7 
1 ’ ’ ’ ’ ’ ’ 
012 3 4 012 3 4 5 6 0123456 
0,025 IJG/KG P,o, 0,25 jJG/KG P,o, *<*I; : pco.05 285 pG/KG P,O, 
X 6 DAYS x 6 DAYS * < *** : pco.01 
SCORE 
ANTIRACHITIC ACTIVITY OF VITAMIN D ANALOGS IN RATS, 
Fig.3. Antirachitic activity of vitamin D, analogs in rats. Weanling male Wistar rats were fed a rachitogenic diet for 3 weeks and 
were given either a single dose or a small daily dose of vitamin D, analogs. Seven days after the first dose, the rats were killed 
and their radii and ulnae were removed to score epiphyseal plate calcification [ 81. There were 7 rats in each group. The horizontal 
bars represent he SEM. 
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intestine [ 111. As above mentioned, both stereo- 
isomers of 1~1,24-(0H)~-D~ have about the same 
activity both on intestine and bone within 10 h after 
administration and after 24 h the S-isomer has lost 
activity. Possible explanations for these findings will 
be the subject of future experiments. 
The presence report establishes that lc~,2d-(OH)~-D~ 
References 
[l] DeLuca, H. F. (1974) Fed. PIOC. 33,221l. 
[2] Holick, M. F., Semmler, E. J., Schnoes, H. K. and 
DeLuca, H. F. (1973) Science 180, 190. 
[3] Makita, T., Uotani, Y., Izawa, Y., Kawashima, H., 
Hashimoto, Y. and Tsubura, Y. (1976) ToxicoL 
AppL PharmacoL 36(2), 323. 
is as potent as l&OH-D3 in the stimulation of intes- 
tinal calcium transport and bone mineral mobilization 
both in normal and anephric rats. In view of these 
facts and its low toxicity (Kawasbima, H. et al. in 
preparation) 101,24-(OH)~-D~ is potentially atractive 
for clinical use in patients with renal failure and other 
metabolic bone diseases. 
[4] Koizumi, N., Morisaki, M;, Ikekawa, N., Suzuki, A. and 
Takeshita, T. (1975) Tetrahedron Lett. 2203. 
[S] Morisaki, M., Koizumi, N., Ikekawa, N., Takeshita, T. 
and Ishimoto, S. (1975) J. Chem. Sot. Perkin I, 1421. 
[6] Martin, D. L. and DeLuca, H. F. (1969) Amer. J. 
PhysioL 216, 351. 
[ 7) Connerty, H. V. and Briggs, A. R. (1966) Amer. J. Clin. 
PathoL 45,290. 
[8] US Pharmacopela (1955) 15th Revision, p. 889. 
[9] Tanaka, Y., Frank, H., DeLuca, H. F., Koizumi, N. and 
Ikekawa, N. (1975) Biochemistry 15,3293. 
[lo] Tanaka, Y., DeLuca, H. F., Ikekawa, N., Morisaki, M. 
and Koizumi, N. (1975) Arch. Biochem. Biophys. 170, 
620. 
[ 111 Holick, M. F., Kleiner-BossalIer, A., Schnoes, H. K., 
Kasten, P. M., Boyle, I. T. and DeLuca, H. F. (1973) J. 
Biol. Chem. 248,669l. 
181 
